GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bluejay Diagnostics BJDX · USD

Health Care · US listing · 🇺🇸 United States

Compare

2.49

+5.96%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Bluejay Diagnostics

From its filings with the US Securities and Exchange Commission

SEC filings

Bluejay Diagnostics is based in Acton, Massachusetts and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker BJDX. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2022, it reported revenue of $249,040.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
10 Nov 2021
Employees
16
Head office
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON, MA, 01720
Incorporated in
DE
Classification
Surgical & Medical Instruments & Apparatus
Filer status
<br>Emerging growth company

Leadership

Pay as last reported

  • Mr. Douglas WurthIndependent Chairman of the Board$97,500
  • Mr. Neil DeyPresident, Chief Executive Officer, Principal Executive Officer, Co-Founder, Principal Financial and Accounting Officer, Director, since 2015$290,887
  • Ms. Svetlana DeyDirector$50,000
  • Mr. Donald ChaseIndependent Director$85,000
  • Mr. Fred ZeidmanIndependent Director$70,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Bluejay Diagnostics Inc focuses on near-patient testing with Symphony System for sepsis triage
  • Symphony IL-6 test provides results in 20 minutes from sample-to-result
  • The Symphony platform measures key diagnostic biomarkers in whole blood

Weaknesses

  • Bluejay Diagnostics employs only 16 full-time employees
  • The company has a limited workforce for a Health Care Equipment & Supplies industry
  • Acton, Massachusetts is a small city for a medical diagnostics company

Opportunities

  • The global in vitro diagnostics devices market includes sepsis, cardio-metabolic diseases, and cancer
  • Symphony System addresses a subset of the IVDS market for disease monitoring
  • The Symphony IL-6 test targets sepsis triage in medical diagnostics

Threats

  • Bluejay Diagnostics has a small workforce of 16 employees
  • The company's IPO on 10 November 2021 may face market volatility
  • Acton, Massachusetts lacks a large medical diagnostics industry hub

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.